Compound Summary
N-arachidonylglycine
Compound Information
N-arachidonylglycine
Compound Name: | N-arachidonylglycine |
Compound CID: | 5283389 |
Synonyms: | N-arachidonylglycine N-arachidonoylglycine NAGly N-arachidonoyl glycine 179113-91-8 More... |
Iupac Name: | 2-[[(5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoyl]amino]acetic acid |
InChI: | InChI=1S/C22H35NO3/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-21(24)23-20-22(25)26/h6-7,9-10,12-13,15-16H,2-5,8,11,14,17-20H2,1H3,(H,23,24)(H,25,26)/b7-6-,10-9-,13-12-,16-15- |
InChIKey: | YLEARPUNMCCKMP-DOFZRALJSA-N |
Canonical Smiles: | CCCCCC=CCC=CCC=CCC=CCCCC(=O)NCC(=O)O |
Isomeric Smiles: | CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)NCC(=O)O |
Molecular Weight: | 361.5 |
Molecular Formula: | C22H35NO3 |
Compound Structure
2D Structure:
3D Structure:
Computed Properties
N-arachidonylglycine
Molecular Weight: | 361.5 |
Molecular Formula: | C22H35NO3 |
Hydrogen Bond Donor Count: | 2 |
Hydrogen Bond Acceptor Count: | 3 |
Rotatable Bond Count: | 16 |
Heavy Atom Count: | 26 |
Complexity: | 476 |
Synonyms
N-arachidonylglycine
| N-arachidonylglycine | N-arachidonylglycine |
|---|---|
N-arachidonylglycine |
N-arachidonoylglycine |
NAGly |
N-arachidonoyl glycine |
179113-91-8 |
arachidonoyl glycine |
NA-Gly |
N-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-glycine |
2-(5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoylaminoacetic acid |
CHEMBL161343 |
C22H35NO3 |
CHEBI:58961 |
NCGC00015042-03 |
DSSTox_CID_25124 |
DSSTox_RID_80688 |
DSSTox_GSID_45124 |
Glycine, N-(5Z,8Z,11Z,14Z)-1-oxo-5,8,11,14-eicosatetraen-1-yl- |
CAS-179113-91-8 |
SR-01000076205 |
N-(1-oxo-5Z,8Z,11Z,14Z-eicosatetraenyl)glycine |
N-1-Oxo-5Z,8Z,11Z,14Z-eicosatetraenylglycine |
Glycine, N-((5Z,8Z,11Z,14Z)-1-oxo-5,8,11,14-eicosatetraen-1-yl)- |
Glycine,N-(5Z,8Z,11Z,14Z)-1-oxo-5,8,11,14-eicosatetraen-1-yl- |
arachidonoylglycine |
arachidonyl glycine |
N-Arachidonyl Glycine |
N-arachidonyl-L-glycine |
Lopac-A-1977 |
UNII-5PB56SQA6E |
5PB56SQA6E |
Lopac0_000074 |
BSPBio_001444 |
N-Arachidonylglycine (NAGly) |
SCHEMBL158050 |
BML2-C05 |
GTPL3635 |
DTXSID5045124 |
HMS1361I06 |
HMS1791I06 |
HMS1989I06 |
HMS3402I06 |
HMS3649B11 |
ZINC4467867 |
Tox21_110070 |
1909AH |
BDBM50056486 |
FA-029 |
LMFA08020003 |
NSC746569 |
AKOS024456602 |
Tox21_110070_1 |
CCG-204169 |
LP00074 |
NSC-746569 |
SDCCGSBI-0050062.P002 |
IDI1_033914 |
NCGC00015042-01 |
NCGC00015042-02 |
NCGC00015042-04 |
NCGC00015042-05 |
NCGC00015042-06 |
NCGC00015042-07 |
NCGC00015042-08 |
NCGC00015042-09 |
NCGC00015042-10 |
NCGC00015042-11 |
NCGC00093582-01 |
NCGC00093582-04 |
NCGC00093582-05 |
NCGC00093582-06 |
NCGC00093582-07 |
NCGC00093582-08 |
NCGC00093582-09 |
B6742 |
EU-0100074 |
A 1977 |
N-arachidonoylglycine, methylene chloride solution |
J-011429 |
N-(1-oxo-5Z,8Z,11Z,14Z-eicosatetrae nyl)glycine |
SR-01000076205-1 |
SR-01000076205-5 |
BRD-K51557114-001-02-1 |
Q18378715 |
((5Z,8Z)-Icosa-5,8,11,14-tetraenoylamino)-acetic acid |
N-(5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoylglycine |
((5Z,8Z,11Z,14Z)-Icosa-5,8,11,14-tetraenoylamino)-acetic acid |
N-((5Z,8Z,11Z,14Z)-1-Oxo-5,8,11,14-eicosatetraen-1-yl)glycine |
Experimental Data
N-arachidonylglycine
| Species | Dose | Unit | Control(Avg days) | Treatment(Avg days) | Avg/Med Lifespan Change(%) | Control(Max days) | Treatment(Max days) | Max Lifespan Change(%) | Significant | Strain | Gender | PubMed | Avg/Med Lifespan Change tab |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Caenorhabditis elegans | 33.000000000000000 | umol/L | 8.000000000000000 | NS | N2 | 24134630 | Inactive |
Experimental Data Visualization
N-arachidonylglycine
Statistics Data
N-arachidonylglycine
| Species | Avg/Med Lifespan Change(%) | Max Lifespan Change(%) | Count Reference | Count Data point |
|---|---|---|---|---|
| Caenorhabditis elegans | 8.000000000000000 | 1 | 1 |
Statistics Data Visualization
N-arachidonylglycine
